| Metal complexes of NSAIDs as potent anti-tumor chemotherapeutics: Mechanistic insights into cytotoxic activity via multiple pathways primarily by inhibition of COX–1 and COX–2 … HY Khan, S Parveen, I Yousuf, S Tabassum, F Arjmand Coordination Chemistry Reviews 453, 214316, 2022 | 32 | 2022 |
| Evaluation of cytotoxic potential of structurally well-characterized RNA targeted ionic non-steroidal anti-inflammatory (NSAID) Cu (II) & Zn (II) DACH–mefenamato drug … HY Khan, S Tabassum, F Arjmand RSC advances 10 (1), 166-178, 2020 | 28 | 2020 |
| Evaluation of cytotoxic activity and genotoxicity of structurally well characterized potent cobalt(II) phen–based antitumor drug entities : An in vitro and in vivo approach. Huzaifa Yasir Khan, Mohd Owais Ansari, G. G. H. A. Shadab, Sartaj Tabassum ... Bioorganic Chemistry, 2019 | 18 | 2019 |
| New tailored RNA-targeted organometallic drug candidates against Huh7 (Liver) and Du145 (Prostate) cancer cell lines HY Khan, SK Maurya, HR Siddique, S Yousuf, F Arjmand ACS omega 5 (25), 15218-15228, 2020 | 16 | 2020 |
| New ionic Cu (II) and Co (II) DACH–flufenamate conjugate complexes: spectroscopic characterization, single x–ray studies and cytotoxic activity on human cancer cell lines HY Khan, S Zehra, S Parveen, I Yousuf, S Tabassum, F Arjmand ChemistrySelect 3 (45), 12764-12772, 2018 | 14 | 2018 |
| Elucidating the interaction of enantiomeric Cu (II) complexes with DNA, RNA and HSA: A comparative study S Parveen, S Jafri, HY Khan, S Tabassum, F Arjmand Polyhedron 210, 115501, 2021 | 8 | 2021 |
| Progress of Metal-Based Anticancer Chemotherapeutic Agents in Last Two Decades and their Comprehensive Biological (DNA/RNA Binding, Cleavage and Cytotoxicity Activity) Studies F Arjmand, HY Khan, S Tabassum The Chemical Record 2023, e202200247, 2023 | 6 | 2023 |
| Advances in anticancer alkaloid-derived metallo-chemotherapeutic agents in the last decade: Mechanism of action and future prospects MF Ansari, HY Khan, S Tabassum, F Arjmand Pharmacology & Therapeutics 241, 108335, 2023 | 6 | 2023 |
| Comprehensive structural {single crystal X-raydiffraction, spectroscopic & DFT computational simulation} and biological {in vitro DNA binding & antibacterial} studies of … HY Khan, MT Zeyad, S Akhter, S Tabassum, F Arjmand Inorganica Chimica Acta 538, 120978, 2022 | 5 | 2022 |
| ACS Omega, 2020, vol. 5 HY Khan, SK Maurya, HR Siddique Article CAS PubMed PubMed Central, 15218, 0 | 4 | |
| Structural insights into interactions of new polymeric (μ–oxo) bridged Cu (II) complexes of taurine with yeast tRNA by spectroscopic and computational approaches and its … S Zehra, HY Khan, T Roisnel, S Tabassum, F Arjmand International Journal of Biological Macromolecules 240, 124429, 2023 | 3 | 2023 |
| A highly selective “on–off” fluorescent sensor for detection of Fe3+ ion in protein and aqueous media: Synthesis, structural characterization, and computational studies R Kouser, HY Khan, F Arjmand, S Tabassum Inorganica Chimica Acta 551, 121484, 2023 | 2 | 2023 |
| Advances of metallodrug-amyloid β aggregation inhibitors for therapeutic intervention in neurodegenerative diseases: Evaluation of their mechanistic insights and neurotoxicity HY Khan, A Ahmad, MN Hassan, YH Khan, F Arjmand, RH Khan Coordination Chemistry Reviews 501, 215580, 2024 | 1 | 2024 |
| Preparation and characterization of ionic metal-based anticancer formulations of the type [bis-DACH tolfenamate metal {Co (II), Cu (II) and Zn (II)}] complexes: Binding studies … HY Khan, S Tabassum, F Arjmand Inorganica Chimica Acta 558, 121725, 2023 | 1 | 2023 |
| DNA Condensation Processes Mediated by Metal-Based Drug Entities and Morphological Studies F Arjmand, S Tabassum, HY Khan Advances and Prospects of 3-d Metal-Based Anticancer Drug Candidates, 131-147, 2024 | | 2024 |
| Advanced Drug Delivery Strategies for Metal-Based Anticancer Drugs F Arjmand, S Tabassum, HY Khan Advances and Prospects of 3-d Metal-Based Anticancer Drug Candidates, 219-242, 2024 | | 2024 |
| Molecular Docking and Computational In Silico Investigations of Metal-Based Drug Agents F Arjmand, S Tabassum, HY Khan Advances and Prospects of 3-d Metal-Based Anticancer Drug Candidates, 149-168, 2024 | | 2024 |
| Biochemical Mechanistic Pathway of Cell Death Induced by Metal-Based Chemotherapeutic Agents F Arjmand, S Tabassum, HY Khan Advances and Prospects of 3-d Metal-Based Anticancer Drug Candidates, 169-202, 2024 | | 2024 |
| Interaction Studies of Metal-Based Anticancer Drug Entities with Potential Therapeutic Targets F Arjmand, S Tabassum, HY Khan Advances and Prospects of 3-d Metal-Based Anticancer Drug Candidates, 73-98, 2024 | | 2024 |
| Endoplasmic Reticulum (ER)-Targeted Metal-Based Anticancer Chemotherapeutic Agents F Arjmand, S Tabassum, HY Khan Advances and Prospects of 3-d Metal-Based Anticancer Drug Candidates, 243-258, 2024 | | 2024 |
